Delivery Order SPE2DB22D3016-SPE2DB25FBJM5
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with a ceiling value of $3,781.37. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,620.65 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Abraxane 100 mg vials. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $8,558.34 worth of ABRAXANE 100 mg vials. The contract has a period of performance through January 31, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, with a...
- This is a $11,248.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRAXANE 100 MG VIALS. The contract has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. The contract is valued at $27,577.40 and carries a firm fixed price structure with an ultimate completion date of October 29, 2025. This is a non-set-aside award issued under competitive procedures, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for ABRAXANE 100 MG VIALS, with a ceiling value of $3,374.68 and a firm fixed price pricing type. The contract has a period of performance through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $65,778.16. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- The Defense Logistics Agency awarded a $8,649.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,650.26 on August 6, 2025, for Paclitaxel Protein-Bound 100mg pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) valued at $8,122.48. This firm fixed-price, non-competitive set-aside contract is scheduled for completion by May 15, 2025, and will be performed at the contractor's Conshohocken facility. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which...